CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millikan, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millikan, R. C.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 217-219, February 2000
© 2000 American Association for Cancer Research


Short Communications

NAT1*10 and NAT1*11 Polymorphisms and Breast Cancer Risk1

Robert C. Millikan2

Department of Epidemiology, School of Public Health, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7400

Several recent epidemiological studies examined the association of N-acetyltransferase (NAT) 1 and 2 genotypes and breast cancer risk. Taken together, these studies do not support a strong role for the most common NAT alleles in etiology of breast cancer. Only one study estimated odds ratios (ORs) for the relatively rare NAT1*11 allele: a strong positive association for the NAT1*11 allele and breast cancer was reported, as well as strong combined effects for NAT1*11-containing genotypes and two environmental factors, smoking and red meat consumption. To further address the association of NAT1*11 and breast cancer, an analysis was performed using previously collected data from the Carolina Breast Cancer Study, a population-based, case-control study conducted in North Carolina. The OR for NAT1*11-containing genotypes and breast cancer was 0.5 (95% confidence interval, 0.2–1.3) among white women; ORs were not calculated among African Americans because only one participant exhibited the NAT1*11 allele. There was no evidence for combined effects of NAT1*11 and smoking. Unfortunately, the results of both studies of NAT1*11 are imprecise and lack sufficient statistical power to address fully the potential contribution of NAT1*11 to breast cancer. These results illustrate that the limitations imposed by sample size, as well as incomplete knowledge of biological function, need to be considered when planning and interpreting studies of genetic polymorphisms and environmental exposures.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. D. Terry and M. Goodman
Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 602 - 611.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. D. Terry and T. E. Rohan
Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 953 - 971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.